Instructions for Soolantra (Ivermectin) 1% cream
English product name
Solantra
Release Form
Cream for outdoor use
Description Soolantra:
Cream for external application 1% from white to light yellow.
1g
ivermectin 10 mg
Auxiliary substances: glycerol - 40 mg, isopropyl palmitate - 40 mg, carbomer copolymer type B - 2 mg, dimethicone 20 Cst - 5 mg, dynatrium edetate - 0.5 mg, citric acid monohydrate - 0.5 mg, cetyl alcohol - 35 mg, stearyl alcohol - 25 mg, macrogol cetosteryl ether - 30 mg, sorbitana stearate - 20 mg, methylparahydroxybenzoate - 2 mg, propyl parahydroxybenzoate - 1 mg, phenoxyethanol 10 mg, propylene glycol - 20 mg, oleyl alcohol - 20 mg, sodium hydroxide solution 10% - to pH 6.3±0.3, water purified - to 1000 mg.
15 g - laminated tubes (1) - cardboard packs.
30 g - laminated tubes (1) - cardboard packs.
ATC codes
D11AX22 Ivermectin
Clinical-pharmacological groups / Group affiliation
Preparation for treating inflammatory skin lesions in rosacea
Active substance
ivermectin
Pharmaco-therapeutic group Soolantra
Antimicrobial and antiskid agent
Pharmacological effect
The agent for external use relates to the group of avermectin. It has an anti-inflammatory effect by suppressing the production of inflammatory cytokines induced by lipopolysaccharides. Anti-inflammatory properties
Testimony Soolantra
Treatment of inflammatory skin lesions in rosacea (papoulet) in adult patients.
Method of use, course and dosage Soolantra
For outdoor use.
It is used once daily for up to four months. If necessary, the treatment can be repeated.
If there is no improvement after three months of use, treatment should be discontinued.
It is applied only to the face.
Use in children
- Use in children and adolescents under the age of 18 years is contraindicated.
- Nosology (ICD codes)
- L71
- Rosacea